Cargando…

Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial

BACKGROUND: Patients with non-alcoholic fatty liver disease (NAFLD) as well as type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular diseases (CVD). Omega-3 supplementation has been proposed as a possible strategy for management of cardiometabolic risk. Cardiometabolic indices can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sangouni, Abbas Ali, Orang, Zahra, Mozaffari-Khosravi, Hassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672492/ https://www.ncbi.nlm.nih.gov/pubmed/34911587 http://dx.doi.org/10.1186/s40795-021-00490-8

Ejemplares similares

Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial
por: Ali Sangouni, Abbas, et al.
Publicado: (2022)

Effect of L-carnitine supplementation on lipid accumulation product and cardiovascular indices in women with overweight/obesity who have knee osteoarthritis: a randomized controlled trial
por: Sangouni, Abbas Ali, et al.
Publicado: (2022)

Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome
por: Nadjarzadeh, Azadeh, et al.
Publicado: (2015)

The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial
por: Nadjarzadeh, Azadeh, et al.
Publicado: (2013)

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation
por: Yang, Jinchunzi, et al.
Publicado: (2019)

Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Yan, Jian-Hui, et al.
Publicado: (2018)

Mediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study
por: Entezari, Mohammad-Reza, et al.
Publicado: (2021)

The effect of anthocyanins supplementation on liver enzymes: A systematic review and meta‐analysis of randomized clinical trials
por: Sangsefidi, Zohreh Sadat, et al.
Publicado: (2021)

Fatty Acid Profile and Cardiometabolic Markers in Relation with Diet Type and Omega-3 Supplementation in Spanish Vegetarians
por: Salvador, Ana M., et al.
Publicado: (2019)

Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non-Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis
por: Lee, Cheng-Han, et al.
Publicado: (2020)

Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: A 12-week double-blind randomized placebo-controlled clinical trial
por: Naderi, Zahra, et al.
Publicado: (2015)

The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial
por: Sangsefidi, Zohreh Sadat, et al.
Publicado: (2019)

Effect of vitamin D supplementation on brain waves, behavioral performance, nitric oxide, malondialdehyde, and high-sensitivity C-reactive protein in children with attention deficit/hyperactivity disorder: study protocol for a randomized clinical trial
por: Sangouni, Abbas Ali, et al.
Publicado: (2022)

Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial
por: Sangouni, Abbas Ali, et al.
Publicado: (2022)

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
por: Janczyk, Wojciech, et al.
Publicado: (2013)

Nigella sativa supplementation and non-alcoholic fatty liver disease: A systematic review of clinical trials
por: Mohtashamian, Abbas, et al.
Publicado: (2023)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

The effect of flaxseed powder on insulin resistance indices and blood pressure in prediabetic individuals: A randomized controlled clinical trial
por: Javidi, Afrooz, et al.
Publicado: (2016)

Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
por: Han, Eugene, et al.
Publicado: (2017)

Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease
por: Klisic, Aleksandra, et al.
Publicado: (2021)

Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: He, Xi-Xi, et al.
Publicado: (2016)

The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD)
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Quality of Bovine Chilled or Frozen-Thawed Semen after Addition of Omega-3 Fatty Acids Supplementation to Extender
por: Abavisani, Abbas, et al.
Publicado: (2013)

Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study
por: Naghipour, Amirhossein, et al.
Publicado: (2023)

Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN)
por: Tobin, Derek, et al.
Publicado: (2018)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Naseri, Kaveh, et al.
Publicado: (2022)

The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: a double blind randomized controlled trial
por: Baghban, Farnaz, et al.
Publicado: (2021)

The effect of conjugated linoleic acids and omega-3 fatty acids supplementation on lipid profile in atherosclerosis
por: Eftekhari, Mohammad Hassan, et al.
Publicado: (2014)

Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease
por: Alberti, Gigliola, et al.
Publicado: (2020)

Blood indices of omega-3 and omega-6 polyunsaturated fatty acids are altered in hyperglycemia
por: Alfhili, Mohammad A., et al.
Publicado: (2023)

Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial
por: Ebrahimi, Zarin sadat, et al.
Publicado: (2017)

The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial
por: Doaei, Saeid, et al.
Publicado: (2021)

Supplementation with omega‐3 or omega‐6 fatty acids attenuates platelet reactivity in postmenopausal women
por: Yamaguchi, Adriana, et al.
Publicado: (2022)

Zinc Supplementation Might Not Affect Serum Leptin and Adiponectin Levels in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
por: TABATABAIE, Mahtab, et al.
Publicado: (2021)

Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?
por: Hegazy, Mona, et al.
Publicado: (2019)

Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
por: Della Pepa, Giuseppe, et al.
Publicado: (2017)

The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study
por: Aneni, Ehimen C., et al.
Publicado: (2020)

Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers—An Overview
por: Santos, Heitor O., et al.
Publicado: (2020)

Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Rafie, Roya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mtmpmpaq4svs6ck1u810msghp3